EFFECTS OF GROUP DETAILING ON THE PRESCRIBING OF LIPID-LOWERING DRUGS - A RANDOMIZED CONTROLLED TRIAL IN SWEDISH PRIMARY-CARE
EFFECTS OF GROUP DETAILING ON THE PRESCRIBING OF LIPID-LOWERING DRUGS - A RANDOMIZED CONTROLLED TRIAL IN SWEDISH PRIMARY-CARE
复制标题
DOI：
10.1016/0895-4356(94)00221-b
复制
发表时间：
1995-05-01
影响因子：
7.2
通讯作者：
ERIKSSON, B
中科院分区：
文献类型：
--
作者：
DIWAN, VK;WAHLSTROM, R;ERIKSSON, B
目的是研究“学术组详细介绍”对瑞典初级保健中降脂药物的处方的影响。进行了一项随机对照试验，随机分组是按组进行的。 134个社区卫生中心的一群医生被随机分配给干预措施和对照组。提供了67个干预卫生中心，由药剂师进行了四个课程，并提供了有关高脂血症管理指南的小组信息。干预健康中心中每月降低脂质药物的处方数量增加，并且增加的增加与30-65岁年龄段的女性对照健康中心的相应变化在统计学上不同（p = 0.03）。在干预健康中心，一线降脂药物的处方增加了20％（p = 0.03）。药剂师向初级保健医生进行的“学术组详细介绍”可能是影响开处方实践的有效方法。
The objective was to study the effect of ''academic group detailing'' on the prescribing of lipid-lowering drugs in Swedish primary care. A randomized controlled trial was conducted, randomization being by group. Groups of doctors at 134 community health centres were randomly allocated to an intervention and a control group. The 67 intervention health centres were offered four sessions, conducted by a pharmacist, with group information on guidelines for the management of hyperlipidaemia. The number of prescriptions of lipid-lowering drugs per month increased in the intervention health centres and the increase was statistically different from the corresponding change in the control health centres among women in the age group 30-65 years (p = 0.03). The prescription of first-line lipid-lowering drugs increased by 20% in the intervention health centres (p = 0.03). ''Academic group detailing'' by pharmacists to primary care doctors can be an effective method for influencing prescribing practices.